Hantz Financial Services Inc. Sells 7,036 Shares of MetLife, Inc. $MET

Hantz Financial Services Inc. cut its stake in MetLife, Inc. (NYSE:MET – Free Report) by 4.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 142,044 shares of the financial services provider’s stock after selling 7,036 shares during the period. Hantz Financial Services Inc.’s holdings in MetLife were worth $13,375,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new stake in MetLife in the 2nd quarter valued at $4,381,692,000. Pzena Investment Management LLC bought a new stake in MetLife in the second quarter valued at $941,792,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in MetLife by 5.9% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,026,518 shares of the financial services provider’s stock worth $509,904,000 after acquiring an additional 336,794 shares in the last quarter. Bank of America Corp DE acquired a new position in MetLife during the second quarter worth $455,424,000. Finally, Legal & General Group Plc bought a new position in shares of MetLife during the second quarter valued at $326,904,000. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

Shares of MET stock opened at $102.67 on Monday. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $106.72. The stock’s fifty day moving average is $98.75 and its 200-day moving average is $86.90. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.21 and a current ratio of 0.21. The stock has a market capitalization of $64.52 billion, a PE ratio of 13.39, a PEG ratio of 0.97 and a beta of 0.79.

MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, topping analysts’ consensus estimates of $2.77 by $0.01. The company had revenue of $20.52 billion during the quarter, compared to the consensus estimate of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The firm’s quarterly revenue was up 18.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.34 earnings per share. Equities research analysts expect that MetLife, Inc. will post 9.91 EPS for the current fiscal year.

MetLife announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, August 5th that allows the company to buy back $3 billion in shares. This repurchase authorization allows the financial services provider to purchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its stock is undervalued.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s dividend payout ratio is presently 30.90%.

Insider Activity at MetLife

In other MetLife news, CEO Michel Khalaf sold 187,425 shares of MetLife stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total value of $19,299,152.25. Following the sale, the chief executive officer owned 759,013 shares of the company’s stock, valued at $78,155,568.61. This trade represents a 19.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.40% of the stock is currently owned by insiders.

Key MetLife News

These are some of the MET news items that stood out recently:

  • Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
  • Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
  • Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article

Analyst Ratings Changes

Several equities research analysts have recently commented on MET shares. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $108.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, October 15th. TD Cowen upped their target price on shares of MetLife from $110.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, October 21st. Jefferies Financial Group increased their target price on shares of MetLife from $103.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Weiss Ratings raised shares of MetLife from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday, November 9th. Finally, UBS Group lifted their price target on shares of MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, October 6th. Fourteen research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and a consensus price target of $107.12.

Read Our Latest Analysis on MET

MetLife Company Profile

(Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.